GRI Bio Insider Trades
NASDAQ: GRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
GRI Bio insider activity
No GRI Bio insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Hertz Walter Marc (Chief Executive Officer) reporting a transaction in 385,510 shares on Apr 21, 2023. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GRI's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
GRI insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 21, 2023 | Chaturvedi VipinChief Scientific Officer | Award | 172,189 | — | Form 4 |
| Apr 21, 2023 | Agro AlbertChief Medical Officer | Award | 172,189 | — | Form 4 |
| Apr 21, 2023 | Hertz Walter MarcChief Executive Officer | Award | 385,510 | — | Form 4 |
| Dec 13, 2022 | Thorell MarellaDirector | other | 28,517 | — | Form 4 |
| Jul 1, 2022 | Thorell MarellaDirector | Award | 38,023 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4